Skip to Main Content

Paper Details

The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer.
Eur J Cancer
4
2023
AR, BRCA genes, BRCA2, HRR gene, HRR genes, PARP, advanced prostate cancer, androgen, androgen receptor, human, human genome, men, metastatic castration-resistant prostate cancer, metastatic prostate cancer, poly [ADP ribose], poly [ADP ribose] polymerase, poly [ADP ribose] polymerases, retinoblastoma, retinoblastoma gene, tumour, tumours
Author NameAffiliation
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
Eleni EfstathiouHouston Methodist Cancer Center
Fred SaadCentre Hospitalier de l'Universite de Montreal, Universite de Montreal
  • 1 - 3

Datasets

Release 1.2